[Federal Register Volume 68, Number 139 (Monday, July 21, 2003)]
[Notices]
[Pages 43108-43113]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-18422]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 04005]


Translating Research Into Action for Diabetes; Notice of 
Availability of Funds

    Application Deadline: September 4, 2003.

A. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 301(a) and 317(k)(2)of 
the Public Health Service Act, (42 U.S.C. section 241(a) and 
247b(k)(2)), as amended. The Catalog of Federal Domestic Assistance 
number is 93.283.

B. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2004 funds for a cooperative agreement 
program for Translating Research Into Action For Diabetes (TRIAD). This 
program addresses the ``Healthy People 2010'' focus area of Diabetes.
    The purposes of this research program are to:
    1. Continue or develop a multi-center study of diabetes within 
managed care settings examining the effect of managed care structure 
and organization using a systematic and standardized approach on 
processes and outcomes of diabetes care using two overarching 
hypotheses. The hypotheses are (1) Managed care structural factors 
(i.e. the ability to track, risk stratify, and/or manage persons with 
diabetes; guideline selection and implementation, patient education, 
experience with managed care, management of referral care, clinician 
incentives, financial barriers to care, and non-financial barriers to 
care) influence process of care (clinical process variables and service 
use process variables, i.e. Glycosylated hemoglobin tested/frequency, 
blood pressure (BP) assessment, lipids tested/frequency, eye exam, foot 
exam done/foot care recommendations, aspirin prescription, nephropathy 
assessment, exercise recommendations, smoking cessation counseling); 
and (2) Managed care structural factors influence long-term outcomes of 
care (glycosylated hemoglobin levels, lipid levels, BP level, quality 
of life, satisfaction with care, medical costs, hospitalization, 
diabetes-related complications).
    2. Conduct systematic research aimed at gaining knowledge to 
improve care for people with diabetes using a standardized protocol 
across research centers. This protocol shall be designed to assess a 
diverse community-dwelling (non-institutionalized) population in terms 
of age (aged 18 or older), gender, race/ethnicity (English and Spanish-
speaking), disease severity, geography, and socioeconomic factors.
    3. Explore applied research questions aimed at delivering and 
evaluating primary prevention strategies for diabetes among people at 
high risk.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP): Help improve the 
availability, process, effectiveness, cost-effectiveness, and health 
outcomes of diabetes-related services provided within managed-care 
settings.

C. Eligible Applicants

    Competition is open to colleges, universities, private non-profit 
and public nonprofit domestic organizations, research institutions, 
faith-based organizations, and managed care organizations.
    Applicants claiming nonprofit status must include evidence of 
nonprofit status with their application.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501 (c) (4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant or loan.

D. Funding

Availability of Funds

    Approximately $3.9 million dollars will be available in FY 2004 to 
fund approximately six awards. It is expected that the average award 
will be $550,000, ranging from $400,000 to $700,000. It is expected 
that the awards will begin on or about February 1, 2004, and will be 
made for a 12-month budget period within a project period of up to five 
years. The National Institute of Diabetes and Digestive and Kidney 
Diseases (NIDDK) will collaborate with CDC in support of the 
enhancement of diabetes prevention and control research through a 
Memorandum of Understanding (MOU) and funding of approximately $500,000 
per year during the five-year project period, and based on the 
availability of funds. These funds are included in the total 
availability of funds above.
    Funding estimates may change.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress demonstrated by investigators in

[[Page 43109]]

attainment of the goals, objectives, and corresponding performance 
measures as evidenced by required reports, and based on the 
availability of funds.

Funding Preferences

    Preference may be given to applicants previously funded under 
Program Announcement 98086 (``Translational Research Centers 
for Diabetes Control Within Managed-Care Settings'') because these 
organizations:
    1. Are geographically located across the nation with access to 
diverse diabetic populations in terms of ethnicity/minority, age, and 
socio-economic factors.
    2. Have proven collaboration in conducting multi-center studies 
using a common protocol with other managed care organizations and 
academic institutions.
    3. Have demonstrated strategies for reaching target diabetic 
population and attaining a very high response rate (70 to 80 percent).
    4. Have established infrastructure, pool of expertise, experienced 
personnel, and capacity to track and maintain (with retention rates 
close to 80 percent) a large diabetic cohort within managed care 
settings.

E. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under 1. Recipient 
Activities, and CDC will be responsible for the activities listed under 
2. CDC Activities.
    1. Recipient Activities
    Recipients will be responsible for the following activities:
    a. Collaborate with other successful recipients and partners. 
Participate in the implementation of a multi-center standardized 
protocol, and in its further development, to include the design of the 
study, design of instruments, development of methods and procedures for 
the study, collection of the data, quality control, analysis and 
interpretation of the data, and dissemination of results.
    b. Assist in the development of a research protocol for 
Institutional Review Board (IRB) review by all cooperating institutions 
participating in the research project that will include longitudinal 
ascertainment of serious health conditions. The local IRB will review 
and approve the protocol on an annual basis.
    c. Assure and maintain the confidentiality of all study data.
    d. Develop standardized and aggregate analytical processes and 
technical reports or manuscripts for peer-reviewed publications as 
appropriate.
    e. Because the previous program announcement 98086 was 
designed using a standardized protocol and standardized data collection 
systems, new applicants must have access to existing data (at baseline, 
and at least one follow-up data collection within 18 months) collected 
in a similar standardized and systematic manner on diabetes patients 
within managed care settings, collected during the previous five years 
that may be appropriate for inclusion with any of the previously funded 
centers so that a diabetic cohort may be followed in a uniform manner. 
Data should have been collected from health plans, provider groups, 
racial and ethnic minority groups with diabetes, and adults over the 
age of 18; and may have been assembled through interviews of health 
plan and provider group leaders, telephone surveys, medical record 
reviews, and administrative data, and other appropriate sources in 
order to further the knowledge already gained.
    f. Work collaboratively with similar organizations and recipients 
in a multi-center study using a common protocol to answer the following 
questions: (1) What is the level of quality of diabetes care and is it 
changing over time? (2) what is the relationship between structural 
aspects of care, for example, use of disease management strategies, 
profit status, management of referral care, guideline implementation 
(at system, provider, and patient levels) and diabetes quality of care, 
intermediate outcomes, and long term health (morbidity, mortality, 
quality of life) and economic outcomes? and (3) what interventions and 
strategies can improve diabetes quality of care and outcomes?
    g. Collaborate in an interactive and ongoing basis with other 
health organizations, provider groups, community groups, etc., as 
necessary, to participate in research assessing the existing and 
changing structures, processes, delivery, and outcomes of care for 
people with diabetes.
    h. Examine the relationship between individual- and area/community-
level socioeconomic characteristics of persons with diabetes and their 
health behaviors, and quality of care (processes and outcomes). These 
objectives will be accomplished through collaboration with other funded 
research centers.
    i. Identify innovative ways of optimizing the delivery of care and 
health outcomes; and identify and test strategies to improve care for 
people with diabetes using rigorous scientific methods and based on 
knowledge gained from this systematic and collaborative research 
program.
    j. Utilize an existing Steering Committee which will consist of the 
Principal Investigators of the research study, and who will serve as 
the governing body for the study.
    k. Follow the standardized protocol and manual(s) of operation to 
be developed by the Steering Committee.
    l. Maintain an effective and adequate management and staffing plan 
with appropriate competencies to gather, analyze, and publish data; and 
collaborate with other recipients and use standardized systems such as 
computer assisted telephone systems, hospital record systems, chart 
review, and administrative data management systems for collecting 
patient data.
    m. Communicate scientifically via publications, abstracts, and 
presentations, the main and secondary findings pertaining to the goals 
of the study.
    n. Perform joint analysis with aggregate data. Performance will be 
measured by evidence that the grantee has demonstrated accomplishment 
of the activities described above in items a through n.
    2. CDC Activities
    CDC will be responsible for the following activities:
    a. Provide assistance on the design of the multi-center study, to 
include assisting with the development of sampling procedures, design 
of the instruments, development of methods and procedures for the 
study, collection of data, analysis and interpretation of data, 
resolution of data quality issues and dissemination of results.
    b. Assist in the development of a standardized research protocol 
for IRB review by all cooperating institutions participating in the 
research project.
    c. Obtain and maintain Certificates of Confidentiality in the form 
of 301(d) and assurance of confidentiality 308(d), as appropriate for 
the study.
    d. Collaborate to produce technical reports or manuscripts for 
peer-reviewed publications as appropriate. Provide assistance for joint 
analysis with aggregate data.
    e. Serve as consultants to the Steering Committee.
    f. Participate in research assessing the existing and changing 
structures, processes, delivery, and outcomes of care for people with 
diabetes.
    g. Provide consultation to examine the relationship between 
individual and community socioeconomic characteristics of persons with 
diabetes and diabetes processes and outcomes of care.
    h. Collaborate with research centers to identify and test 
strategies to improve

[[Page 43110]]

care for people with diabetes using rigorous scientific methods.

F. Content

Applications

    The Program Announcement title and number must appear in the 
application. Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, therefore, it is important to follow them in presenting your 
program plan. The narrative should be no more than 50 double-spaced 
pages, printed on one side, with one-inch margins, and unreduced 12-
point font.
    Beginning October 1, 2003, applicants will be required to have a 
Dun and Bradstreet (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge.
    Although obtaining a DUNS number is not required for applications 
submitted in response to announcements with deadlines on or before 
September 30, 2003, regardless of when the award is made, you are 
encouraged to obtain a DUNS number now if you believe you will be 
submitting an application to any Federal agency on or after October 1, 
2003. Proactively obtaining a DUNS number at the current time will 
facilitate the receipt and acceptance of applications after September 
2003.
    To obtain a DUNS number, access: http://www.dunandbradstreet.com or 
call 1-866-705-5711.
    Focus the application content on the planned ``Recipient 
Activities'' and describe accomplishments in the Background and Need 
section of your narrative. Provide supporting documentation such as 
resumes, job descriptions, and descriptions of collaborators as 
appropriate. The original and each copy of the application must be 
submitted unstapled and unbound. Pages should be clearly numbered and a 
complete index to the application and any appendices should be 
included.
    1. Program Narrative
    Under a section entitled Background and Need, describe the extent 
to which the applicant demonstrates an effective understanding of the 
burden of diabetes, the problems (structure, process of care, quality 
of care, endpoints, and outcomes); specific accomplishments of your 
diabetes research program, unmet needs, a need for the project, and a 
commitment to its execution. Describe your capacity to conduct a multi-
center research study in managed care settings. Provide a detailed plan 
of activities to be performed in the first year. Briefly address 
activities for years 2-5.
    2. Provide specific references to the following program 
requirements as described in the Recipient Activities section.
    a. Provide evidence of participation and collaboration with other 
partners in a multi-center study. Provide evidence that the principal 
investigator has published reports emanating from multi-center 
investigations using common protocols of the relationship between 
structural factors and outcomes of diabetes care. Provide evidence of 
experience with developing and working with a multi-center standardized 
protocol to include the design of the study, design of instruments, 
development of methods and procedures for the study, collection of the 
data, quality control, analysis and interpretation of the data, and 
dissemination of results. Applicant must provide a copy of an approved 
protocol (as an attachment to the application) that describes the 
criteria listed above.
    b. Provide evidence that the applicant and principal investigator 
have experience in the development of a research protocol for IRB 
review that includes multiple cooperating institutions participating in 
the research project and that will include longitudinal ascertainment 
of serious health conditions. Provide evidence that the local IRB will 
review and approve the protocol on an annual basis. Provide evidence of 
experience dealing with the challenges and solutions related to 
collecting data in a standardized manner within a multi-center study. 
For example, provide a narrative describing methods used to evaluate 
recruitment, retention, and show data on response rates obtained.
    c. Provide evidence that applicant will assure and maintain the 
confidentiality of all study data.
    d. Provide evidence that applicant can develop standardized and 
aggregate analytical processes and technical reports or manuscripts, 
from multi-center studies using a common protocol, for peer-reviewed 
publications as appropriate.
    e. Provide evidence that applicant has access to research 
infrastructure; and provide summaries of existing data collected during 
the previous five years, linking structural characteristics (for 
example, use of disease management strategies, profit status, 
management of referral care, and guideline implementation) with patient 
level data, including that obtained from surveys, medical record 
reviews, and administrative health care utilization data access to 
existing data on diabetes patients within managed care settings, from 
health plans, provider groups, racial and ethnic minority groups with 
diabetes, and adults over the age of 18; assembled at a minimum through 
telephone surveys, medical record reviews, and administrative data, in 
order to further the knowledge already gained.
    f. Provide evidence that applicant can and is willing to work 
collaboratively with the other recipients to answer the following 
questions: (1) What is the level of quality of diabetes care and is it 
changing over time? (2) What is the relationship between structural 
aspects of care, for example, use of disease management strategies, 
profit status, management of referral care, guideline implementation 
(at system, provider, and patient levels) and diabetes quality of care, 
intermediate outcomes, and long term health (morbidity, mortality, 
quality of life) and economic outcomes? and, (3) what interventions and 
strategies can improve diabetes quality of care and outcomes?
    g. Provide evidence of applicant's ability to collaborate in an 
interactive and ongoing basis with other health organizations, provider 
groups, community groups, etc., as necessary, to participate in 
research assessing the existing and changing structures, processes, 
delivery, and outcomes of care for people with diabetes. Provide 
evidence in the form of multi-center aggregate data wherein key 
structural factors, processes, and outcomes of care are collected 
uniformly across research centers.
    h. Provide evidence that the applicant has experience in examining 
the relationship between individual- and area/community-level 
socioeconomic characteristics of persons with diabetes and their health 
behaviors, and quality of care (processes and outcomes). These 
objectives will be accomplished through collaboration with other funded 
research centers.
    i. Provide evidence that the applicant will focus on finding 
innovative ways of optimizing the delivery of care and health outcomes 
and will identify and test strategies to improve care for people with 
diabetes using rigorous scientific methods and based on knowledge 
gained from this systematic and collaborative research program.
    j. Provide evidence that the principal investigator will be willing 
to utilize an existing Steering Committee which will consist of the 
Principal Investigators of

[[Page 43111]]

the research study and who will serve as the governing body for the 
study.
    k. Provide evidence that recipient will follow the standardized 
protocol and manual(s) of operation to be developed by the Steering 
Committee.
    l. Provide evidence that the applicant will maintain an effective 
and adequate management and staffing plan, including an experienced and 
published principal investigator for the project who has experience in 
the management and oversight of a multi-center study.
    m. Provide evidence of collaboration with others, and experience 
with the use of standardized systems such as computer assisted 
telephone systems, hospital record systems, chart review, and 
administrative data management systems for collecting patient data.
    n. Provide evidence of applicant's experience and willingness to 
perform joint analysis with aggregate data from the study.
    o. Provide evidence of applicant's willingness to communicate 
scientifically via publications, abstracts, and presentations, the main 
and secondary findings pertaining to the goals of the study.
    3. Provide a detailed budget and line-item justification for the 
first year that is consistent with the stated objectives. Applicants 
are asked to include travel for up to three project staff, including 
the principal investigator, to attend four Steering Committee Meetings. 
For panel review purposes, the Program Narrative must be separate from 
the budget justification and budget summaries.

G. Submission and Deadline

Application Forms

    Submit the original and two copies of PHS-398 (OMB Number 0925-
0001). Adhere to the instructions on the Errata sheet (posted on the 
CDC Web site) for specific CDC instructions for the PHS 398 form. Forms 
are available at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) at: 770-488-2700. Application forms can be mailed to you.

Submission Date, Time, and Address

    The application must be received in the CDC Procurement and Grants 
Office by 4 p.m. Eastern Time. September 4, 2003. Submit the 
application to: Technical Information Management-PA 04005, 
Procurement and Grants Office, Centers for Disease Control and 
Prevention, 2920 Brandywine Rd., Atlanta, GA 30341-4146.
    Applications may not be submitted electronically.

CDC Acknowledgement of Application Receipt

    A postcard will be mailed by PGO-TIM, notifying you that CDC has 
received your application.

Deadline

    Applications shall be considered as meeting the deadline if they 
are received in the CDC Procurement and Grants Office before 4 p.m. 
Eastern Time on the deadline date. Any applicant who sends their 
application by the United States Postal Service or commercial delivery 
services must ensure that the carrier will be able to guarantee 
delivery of the application by the closing date and time. If an 
application is received after closing due to (1) carrier error, when 
the carrier accepted the package with a guarantee for delivery by the 
closing date and time, or (2) significant weather delays or natural 
disasters, CDC will upon receipt of proper documentation, consider the 
application as having been received by the deadline.
    Any application that does not meet the above criteria will not be 
eligible for competition, and will be discarded. The applicant will be 
notified of their failure to meet the submission requirements.

A. Evaluation Criteria

Application

    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goals as stated in the Purpose section of 
this announcement. Measures must be objective and quantitative and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    An independent review group appointed by CDC will evaluate each 
application against the following criteria (100 points total):
    1. The extent to which the applicant addresses the specific Content 
1.(a) through 1.(o), below. Total Score 95 points:
    (a) Provide evidence of participation and collaboration with other 
partners in a multi-center study using a common protocol. Provide 
evidence that the Principal Investigator has published reports 
emanating from multi-center investigations of the relationship between 
structural factors and outcomes of diabetes care. Provide evidence of 
experience in developing and working with multi-center standardized 
protocol to include the design of the study, design of instruments, 
development of methods and procedures for the study, collection of the 
data, quality control, analysis and interpretation of the data, and 
dissemination of results. Provide copy of an approved standardized, 
common protocol that includes the criteria listed above, and 
implemented by the applicant. (10 points)
    (b) Provide evidence that applicant and principal investigator have 
experience in the development of a research protocol for IRB review 
that includes multiple cooperating institutions participating in the 
research project that will include longitudinal ascertainment of 
serious health conditions. Provide evidence that the local IRB will 
review and approve the protocol on an annual basis. Provide evidence of 
experience dealing with the challenges and solutions related to 
collecting data in a standardized manner within a multi-center study. 
For example, provide a narrative describing methods used to evaluate 
recruitment, retention, and show data on response rates obtained. (10 
points)
    (c) Provide evidence that applicant can and will develop 
standardized and aggregate analytical processes and technical reports 
or manuscripts, from multi-center studies using a common protocol, for 
peer-reviewed publications as appropriate. (10 points)
    (d) Provide evidence that applicant has access to research 
infrastructure. Provide summaries of existing data collected during the 
previous five years, linking structural characteristics (for example, 
use of disease management strategies, profit status, management of 
referral care, and guideline implementation) with patient level data 
(for example, data obtained from surveys, medical record reviews, 
administrative health care utilization data, existing data on diabetes 
patients within managed care settings, from health plans, provider 
groups, racial and ethnic minority groups with diabetes, and adults 
over the age of 18) assembled at a minimum through telephone surveys, 
medical record reviews, and administrative data, in order to further 
the knowledge already gained. (10 points)
    (e) Provide evidence that applicant can and is willing to work 
collaboratively with the other recipients to answer the following 
questions: (1) What is the level of quality of diabetes care and is it 
changing over time? (2)

[[Page 43112]]

what is the relationship between structural aspects of care, for 
example, use of disease management strategies, profit status, 
management of referral care, guideline implementation (at system, 
provider, and patient levels) and diabetes quality of care, 
intermediate outcomes, and long term health (morbidity, mortality, 
quality of life) and economic outcomes? and, (3) what interventions and 
strategies can improve diabetes quality of care and outcomes? (10 
points)
    (f) Provide evidence of applicant's ability to collaborate in an 
interactive and ongoing basis with other health organizations, provider 
groups, community groups, etc., as necessary, to participate in 
research assessing the existing and changing structures, processes, 
delivery, and outcomes of care for people with diabetes. Provide 
evidence in the form of multi-center aggregate data wherein key 
structural factors, processes, and outcomes of care are collected 
uniformly across research centers. (6 points)
    (g) Provide evidence that the applicant will maintain an effective 
and adequate management and staffing plan, including an experienced and 
published principal investigator for the project who has experience in 
the management and oversight of a multi-center research study. (5 
points)
    (h) Provide evidence of collaboration with other organizations and 
experience with the use of standardized systems such as computer 
assisted telephone systems, hospital record systems, chart review, and 
administrative data management systems for collecting patient data. (5 
points)
    (i) Provide evidence of applicant's experience and willingness to 
perform joint analysis with aggregate data, collected using a common 
protocol from the study. (5 points)
    (j) Provide evidence of applicant's willingness to communicate 
scientifically via publications, abstracts, and presentations, the main 
and secondary findings pertaining to the goals of the study. (5 points)
    (k) Provide evidence that applicant will assure and maintain the 
confidentiality of all study data. (5 points)
    (l) Provide evidence that the applicant will follow the 
standardized protocol and manual(s) of operation to be developed by the 
Steering Committee. (5 points)
    (m) Provide evidence of applicant's ability to examine the 
relationship between individual and area/community level socioeconomic 
characteristics of persons with diabetes and their health behaviors, 
and quality of care (processes and outcomes). These objectives will be 
accomplished through collaboration with other funded research centers. 
(3 points)
    (n) Provide evidence that the applicant will focus on finding 
innovative ways of optimizing the delivery of care and health outcomes, 
and will identify and test strategies to improve care for people with 
diabetes using rigorous scientific methods based on knowledge gained 
from this systematic and collaborative research program. (3 points)
    (o) Provide evidence that the principal investigator will be 
willing to utilize an existing Steering Committee which will consist of 
the Principal Investigators of the research study and who will serve as 
the governing body for the study. (3 points)
    2. Background and Program Need (Total 5 points). The extent to 
which the applicant demonstrates an effective understanding of the 
background and burden of diabetes, the problems (structure, process of 
care, quality of care, endpoints, and outcomes), specific 
accomplishments of your diabetes research program, unmet needs, a need 
for the project, and a commitment to its execution.
    3. Budget and justification (Reviewed, but not weighted or scored).
    Provide a detailed budget and line-item justification for the first 
year that is consistent with the stated objectives and planned 
activities. Applicant is asked to include travel for up to three 
project staff, including the principal investigator, to attend four 
steering committee meetings. For panel review purposes, the program 
narrative must be separate from the budget justification and budget 
summaries.
    4. Human Subjects (Reviewed, but not weighted or scored) Does the 
application adequately address the requirements of title 45 CFR part 46 
for the protection of human subjects? The degree to which the applicant 
has met the CDC Policy requirements regarding the inclusion of women, 
ethnic, and racial groups in any proposed research. This includes:
    a. The proposed plan for the inclusion of both sexes and racial and 
ethnic minority populations for appropriate representation.
    b. The proposed justification when representation is limited or 
absent.
    c. A statement as to whether the design of the study is adequate to 
measure differences when warranted.
    d. A statement as to whether the plans for recruitment and outreach 
for study participants include the process of establishing partnerships 
with community(ies) and recognition of mutual benefits.

I. Other Requirements

Technical Reporting Requirements

    Provide CDC with an original plus two copies of:
    1. Interim progress report, no less than 90 days before the end of 
the budget period. The progress report will serve as your non-competing 
application, and must contain the following:
    a. Current Budget Period Activities/Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activities/Objectives
    d. Detailed, Line-Item Budget Justification.
    e. Additional Requested Information.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial status report, no more than 90 days after the 
end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.

Additional Requirements

    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I of the 
program announcement as posted on the CDC web site.

AR-1 Human Subjects Requirements
AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-7 Executive Order 12372 Review
AR-8 Public Health System Reporting Requirements
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-15 Proof of Non-Profit Status
AR-22 Research Integrity

J. Where To Obtain Additional Information

    This and other CDC announcements, the necessary applications, and 
associated forms can be found on the CDC Web site, Internet address: 
http://www.cdc.gov.
    Click on ``Funding'' then ``Grants and Cooperative Agreements''.
    For general questions about this announcement, contact: Technical

[[Page 43113]]

Information Management, CDC Procurement and Grants Office, 2920 
Brandywine Rd, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For business management and budget assistance, contact: Angela 
Webb, Grants Management Specialist, Procurement and Grants Office, 
Centers for Disease Control and Prevention, 2920 Brandywine Road, 
Atlanta, GA 30341-4146, Telephone: (770) 488-2784, E-mail address: 
[email protected].
    For program technical assistance, contact: Bernice A. Moore, MBA, 
Division of Diabetes Translation, Epidemiology and Statistics Branch, 
Chronic Disease Prevention and Health Promotion, Centers for Disease 
Control and Prevention, 4770 Buford Hwy., NE., MS-K10, Atlanta, GA 
30341-3717, Telephone number: (770) 488-1257, E-mail address: [email protected].

    Dated: July 15, 2003.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 03-18422 Filed 7-18-03; 8:45 am]
BILLING CODE 4163-18-P